Immunogenicity of inactivated coronavirus disease 2019 vaccines in patients with chronic hepatitis B undergoing antiviral therapy

OBJECTIVES: To investigate the effect and its mechanisms of different antiviral agents on the immunogenicity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines in patients with chronic hepatitis B (CHB). METHODS: A total of 125 patients with CHB receiving nucleos(t)ide analogs...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Wen-Xin, Jia, Rui, Song, Jin-Wen, Zhang, Xiaoning, Zhou, Shuang-Nan, Wang, Fu-Sheng, Fu, Junliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748573/
https://www.ncbi.nlm.nih.gov/pubmed/36532454
http://dx.doi.org/10.3389/fmicb.2022.1056884

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748573/
https://www.ncbi.nlm.nih.gov/pubmed/36532454
http://dx.doi.org/10.3389/fmicb.2022.1056884

Ejemplares similares